MEDI0457 Plus Durvalumab in HPV-associated HNSCC-Letter. Mori K, Notsu A, Miura K, Onozawa Y, et al. Clin Cancer Res 2023;29:2735.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mori K, Notsu A, Miura K, Onozawa Y, et al. MEDI0457 Plus Durvalumab in HPV-associated HNSCC-Letter. Clin Cancer Res 2023;29:2735.
PMID: 37449359